, , ,

Project REWIND (REal World evidence IN rheumatic Diseases)

The use of real-world data (RWD) represents one of the most powerful tools for assessing the transferability of scientific evidence into clinical practice today. In recent years, several tools and networks have been developed with the aim of…
,

SHARP: first published study

The harmonization of national severe asthma registries towards OMOP carried out within the SHARP project (more details here) has started to bring results. A first, proof-of-principle study using the "SHARP federated analysis platform" (SHARP…
,

BIOMERIS is the first italian SME certified by EHDEN

European Health Data & Evidence Network (EHDEN), an IMI 2 consortium with 22 partners which will operate in Europe for the coming five years, 2018 – 2024. EHDEN is part of IMI’s Big Data for Better Outcomes (BD4BO) programme. The…